Close Menu
NEW YORK (GenomeWeb News) — Clinical Data today said that affiliates of company chairman RJ Kirk exercised warrants for $3.7 million in shares.
 
The purchase for 190,505 shares of the company’s common stock, valued at $19.45 a share, came from warrants issued in June 2006, the company said.
 
Clinical Data President and CEO Drew Fromkin said the cash “strengthens the company’s balance sheet and provides additional liquidity” to support the third phase of clinical trials for Vilazodone, among other projects.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.